Table 1.
Baseline characteristics compared between responders and non-responders.
| Responder (n = 34) | Non-Responder (n = 17) | p-value | |
|---|---|---|---|
| Male/Female (n) | 2/32 | 5/12 | <0.02 |
| Age (years) | 40 (12) | 46 (13) | ns |
| Fibromyalgia (n) | 19 | 9 | ns |
| Disease duration (years) | 15.2 (8.8) | 16.7 (10.3) | ns |
| Number of steps pre | 3480 (2393) | 4246 (2888) | <0.01 |
| Number of steps post | 5773 (2137) | 6024 (2304) | <0.05 |
| RAND-36 physical activity pre (%) | 34 (18) | 51 (21) | <0.01 |
| RAND-36 physical activity post (%) | 41 (18) | 53 (20) | ns |
| CIS20r fatigue scale pre | 52 (5) | 49 (7) | ns |
| CIS20r fatigue scale post | 50 (6) | 49 (7) | ns |
| CIS20r concentration pre | 29 (4) | 26 (9) | ns |
| CIS20r concentration post | 29 (4) | 26 (9) | ns |
| B12 levels pre (pmol/l) | 379 (294;437) | 265 (228;360) | <0.05 |
| B12 levels post (pmol/l) | 1445 (975;1476) | 395 (356;452) | <0.0001 |
| Thyroid medication (n) | 2 | 1 | ns |
| Analgesics (n) | 10 | 3 | ns |
N, number; pre, pre-treatment; post, post-treatment; B12 levels presented as median and IQR; ns, not significant.